Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues
|
Buy Now
Biopharmaceutical Applied Statistics Symposium - Volume 3 Pharmaceutical Applications (Paperback, Softcover reprint of the original 1st ed. 2018)
Loot Price: R2,832
Discovery Miles 28 320
|
|
Biopharmaceutical Applied Statistics Symposium - Volume 3 Pharmaceutical Applications (Paperback, Softcover reprint of the original 1st ed. 2018)
Series: ICSA Book Series in Statistics
Expected to ship within 10 - 15 working days
|
This BASS book Series publishes selected high-quality papers
reflecting recent advances in the design and biostatistical
analysis of biopharmaceutical experiments - particularly
biopharmaceutical clinical trials. The papers were selected from
invited presentations at the Biopharmaceutical Applied Statistics
Symposium (BASS), which was founded by the first Editor in 1994 and
has since become the premier international conference in
biopharmaceutical statistics. The primary aims of the BASS are: 1)
to raise funding to support graduate students in biostatistics
programs, and 2) to provide an opportunity for professionals
engaged in pharmaceutical drug research and development to share
insights into solving the problems they encounter. The BASS book
series is initially divided into three volumes addressing: 1)
Design of Clinical Trials; 2) Biostatistical Analysis of Clinical
Trials; and 3) Pharmaceutical Applications. This book is the third
of the 3-volume book series. The topics covered include: Targeted
Learning of Optimal Individualized Treatment Rules under Cost
Constraints, Uses of Mixture Normal Distribution in Genomics and
Otherwise, Personalized Medicine - Design Considerations, Adaptive
Biomarker Subpopulation and Tumor Type Selection in Phase III
Oncology Trials, High Dimensional Data in Genomics; Synergy or
Additivity - The Importance of Defining the Primary Endpoint, Full
Bayesian Adaptive Dose Finding Using Toxicity Probability Interval
(TPI), Alpha-recycling for the Analyses of Primary and Secondary
Endpoints of Clinical Trials, Expanded Interpretations of Results
of Carcinogenicity Studies of Pharmaceuticals, Randomized Clinical
Trials for Orphan Drug Development, Mediation Modeling in
Randomized Trials with Non-normal Outcome Variables, Statistical
Considerations in Using Images in Clinical Trials, Interesting
Applications over 30 Years of Consulting, Uncovering Fraud,
Misconduct and Other Data Quality Issues in Clinical Trials,
Development and Evaluation of High Dimensional Prognostic Models,
and Design and Analysis of Biosimilar Studies.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.